The fetal DNA analysis during pregnancy is a non-invasive practice that allows early detection of potential genetic anomalies.
This technique, also known as prenatal testing, can identify conditions such as:
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Certain sex chromosome aneuploidies
It provides vital information to healthcare professionals and expectant parents for pregnancy development and informed decision-making.
What is Free Fetal DNA and How is it Detected?
Free fetal DNA (cffDNA) refers to DNA fragments found in maternal blood during pregnancy, originating from both the mother and fetus, specifically from the feto-placental unit. The main source of fetal DNA is apoptosis of syncytiotrophoblast cells in the placenta. This DNA can be detected in maternal circulation from around five weeks gestation, with detectable levels typically by nine weeks.
The primary source of fetal DNA is apoptosis of syncytiotrophoblast cells, a layer of placental cells. This DNA can be detected in maternal circulation starting from the fifth week of gestation, becoming consistently detectable by week nine.
Detection of fetal DNA is achieved through advanced sequencing techniques. The circulating DNA is highly fragmented, with each fragment containing between 50 and 200 base pairs (in standard sequencing tests, base pairs range from 100 to 1000). New sequencing techniques and technologies have enabled the identification and analysis of these fragments, distinguishing between maternal and fetal origins based on fragmentation patterns and size.
Types of Non-Invasive Prenatal Screening Tests
In addition to free fetal DNA analysis, other non-invasive prenatal tests aid in detecting genetic anomalies:
First trimester combined screening: Includes an ultrasound to measure fetal nuchal translucency (helps identify chromosomal problems like Down syndrome) and a blood test to measure levels of specific proteins and hormones (such as Patau syndrome).
Second trimester quadruple screening: Evaluates four substances in maternal blood to detect potential anomalies. These include alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. This practice assesses the risk of Down syndrome and can also detect neural tube defects and other issues.
Detailed ultrasounds: Allow visualization of fetal anatomy and can identify structural physical deformities such as heart defects, spina bifida, brain problems, kidneys, or other parts of the body and even, obvious chromosomal and genetic anomalies.
Although useful, these tests do not reach the precision of free fetal DNA analysis, which has a detection rate exceeding 99% for trisomy 21 when the sample is adequate.
Advantages and Limitations of Fetal DNA Analysis
Advantages:
High precision: Capable of detecting more than 99% of cases of trisomy 21.
Non-invasive: No risk of abortion, unlike amniocentesis or chorionic villus sampling.
Early detection: Possible starting from the 9th week of gestation.
Limitations:
False positives/negatives: Although rare, cases where results are inconclusive exist.
Not a definitive diagnosis: A confirmatory invasive test is recommended in case of positive results.
Dependence on fetal fraction: Requires a minimum of 3-4% fetal DNA in the sample to be effective.
Clinical Applications of Fetal DNA Analysis
Fetal DNA analysis is primarily used for trisomy detection but also applies to:
Detection of sex chromosome aneuploidies: This includes abnormalities in sex chromosomes X and Y, such as Turner syndrome (monosomy X), Klinefelter syndrome (XXY trisomy), and other sex chromosome variations.
Identification of microdeletions: Loss of small chromosome fragments causing genetic syndromes such as DiGeorge syndrome (loss in chromosome 22q11), Wolf-Hirschhorn syndrome (deletion in the short arm of chromosome 4), and Prader-Willi/Angelman syndrome (loss in chromosome 15q11-q13).
Detection of other genetic disorders: Depending on the panel used, various genetic conditions that may be hereditary or arise from new mutations can be identified. This includes monogenic diseases such as cystic fibrosis, muscular dystrophy, cancer predisposition syndromes, among others.
This type of analysis offers parents a safer and less invasive option to assess their future child's genetic health during prenatal diagnosis.
Procedure for Fetal DNA Testing in Maternal Blood
The procedure for conducting a fetal DNA test is similar to a regular blood test:
Blood extraction: First, a small sample of blood is drawn from the mother using a fine needle, similar to when blood is drawn for a routine test.
Plasma separation: Once the blood sample is obtained, it is processed in the laboratory to separate the plasma. Plasma is the liquid part of blood containing small fragments of free DNA.
DNA sequencing: Next, sequencing of the free DNA present in the plasma is performed. This involves analyzing and identifying DNA fragments belonging to the fetus.
Data analysis: The data obtained during sequencing is carefully analyzed to look for possible genetic anomalies, as mentioned earlier.
This procedure, although straightforward, is conducted in a specialized laboratory equipped with the necessary equipment and technology to perform sequencing and analysis accurately, safely, and under the guidance of trained personnel.
It is a simple and routine practice that does not cause significant pain or pose a major risk to the mother or the baby. The test results will help the doctor obtain important information about the baby's genetic health during gestation.
Precision and Reliability of Fetal DNA Tests
As mentioned, the precision of fetal DNA analysis is highly reliable, especially in trisomy detection. With a detection rate of 99% for trisomy 21 and similar rates for other trisomies and aneuploidies.
However, it is important to remember that this test is for detection and not diagnostic.
Positive results should be confirmed through invasive tests such as amniocentesis or chorionic villus sampling.
Comparison with Other Prenatal Tests
Compared to traditional invasive tests such as amniocentesis and chorionic villus sampling, fetal DNA analysis offers a safe and effective alternative without the risk of complications associated with invasive techniques.
Using these other tests only in cases of high suspicion
.
Although combined and quadruple tests are also non-invasive, they do not match the precision of fetal DNA analysis, especially in trisomy detection.
Considerations and Recommendations
The use of fetal DNA analysis raises important ethical considerations. The possibility of knowing detailed genetic information about the fetus from very early stages of pregnancy can lead to difficult decisions for prospective parents.
Therefore, it is especially important for healthcare professionals to provide adequate genetic counseling, clearly explaining the benefits and limitations of the test.
It may be wise for the doctor to opt for other more common tests within regular pregnancy check-ups, and consider fetal DNA analysis in cases where this process can rule out, always taking into account the mother's emotional state, as pregnancy creates hormonal variations that make her more sensitive to any kind of news and/or stimulus.
Future Innovations in Fetal DNA Analysis
The future of fetal DNA analysis appears to aim at:
Greater precision and scope: Ability to detect a wider range of genetic conditions with greater accuracy.
Earlier and less invasive tests: Development of techniques that allow detection even before nine weeks.
Cost reduction: Making these tests more accessible to a larger population.
Prenatal detection of genetic anomalies will continue to evolve, providing prospective parents and healthcare professionals with increasingly advanced tools for prenatal care and planning.
But if you want to take action even before becoming a mom or dad you can continue reading about what your DNA tells about you.
Comments